SEC Form 4 · accession 0001237899-15-000055
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George L Sing
Director
Period of report
Nov 18, 2015
Accepted (ET)
Nov 20, 2015 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 18, 2015 | M | 3,000 | $19.69 | A | 115,772 | D | |
| Common Stock | Nov 18, 2015 | S | 3,000 | $580.00 | D | 112,772 | D | |
| Common Stock | Nov 18, 2015 | S | 500 | $580.00 | D | 4,500 | I | by Spouse/Cust Son |
| Common Stock | holding | — | — | — | 3,000 | I | by Spouse | |
| Common Stock | holding | — | — | — | 10,000 | I | by Trust for Son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $19.69 | Nov 18, 2015 | M | 3,000 | D | — | Jan 3, 2017 | Common Stock | 3,000 | 7,000 | D |
Explanation of responses
- F1The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.